Every open market buy and sale of Aquestive Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $99K bought and $2.4M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when AQST insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an AQST officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every AQST insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Matthew W. DavisChief Development Officer | Sale plan | 7,197 | $3.55 | $26K | 87,500 | Nov 16Form 4 |
| Nov 10, 2026 | Richard J DalyDirector | Buy | 28,025 | $3.54 | $99K | 28,025 | Nov 12Form 4 |
| Oct 15, 2026 | Daniel BarberPresident and CEO | Sale plan | 25,000 | $4.22 | $106K | 627,317 | Oct 16Form 4 |
| Sep 15, 2026 | Daniel BarberPresident and CEO | Sale plan | 25,000 | $4.82 | $120K | 652,317 | Sep 16Form 4 |
| Sep 9, 2026 | Sherry KorczynskiChief Commercial Officer | Sale plan | 8,750 | $5.22 | $46K | 235,689 | Sep 11Form 4 |
| Aug 17, 2026 | Daniel BarberPresident and CEO | Sale plan | 25,000 | $4.29 | $107K | 585,574 | Aug 18Form 4 |
| Jul 16, 2026 | Daniel BarberPresident and CEO | Sale plan | 25,000 | $4.01 | $100K | 610,574 | Jul 17Form 4 |
| Jun 23, 2026 | Julie KropDirector | Sale plan | 25,000 | $5.02 | $125K | 0 | Jun 24Form 4 |
| Jun 15, 2026 | Daniel BarberPresident and CEO | Sale plan | 25,000 | $4.16 | $104K | 635,574 | Jun 16Form 4 |
| May 15, 2026 | Daniel BarberPresident and CEO | Sale plan | 8,257 | $4.29 | $35K | 660,574 | May 18Form 4 |
| Mar 10, 2026 | Cassie JungCOO | Sale | 45,791 | $4.17 | $191K | 274,980 | Mar 11Form 4 |
| Mar 10, 2026 | Sherry KorczynskiChief Commercial Officer | Sale | 15,741 | $4.17 | $66K | 241,117 | Mar 11Form 4 |
| Mar 10, 2026 | A Ernest Toth JrCFO | Sale | 58,254 | $4.17 | $243K | 376,112 | Mar 11Form 4 |
| Mar 10, 2026 | Melina CioffiSVP, Regulatory Affairs | Sale | 25,311 | $4.17 | $106K | 274,867 | Mar 11Form 4 |
| Mar 10, 2026 | Lori J BraenderChief Legal Officer | Sale | 40,102 | $4.17 | $167K | 442,879 | Mar 11Form 4 |
AQST insider trading FAQ
Are AQST insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $99K of AQST on the open market in 1 trades, and 9 sold $2.4M in 16 trades, 32% of that under pre-arranged trading plans.
When did an AQST insider last buy shares?
Richard J Daly (Director) bought 28,025 shares for $99K on Nov 10, 2026, reported on Nov 12, 2026.
When did an AQST insider last sell shares?
Matthew W. Davis (Chief Development Officer) sold 7,197 shares for $26K on Nov 12, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
